Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Cross-Sectional

Outcome Measure:

Health-related quality of life as measured by the EORTC QLQ C30 and BLS24 (nonmuscle-invasive) or BLM30 (muscle-invasive or metastatic)

Outcome Description:

Health-related quality of life as measured by the European Organization for Resarch and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) C30 and BLS24 (that is, BLadder cancer Superficial, meaning nonmuscle-invasive) or BLM30 (BLadder cancer muscle-invasive or metastatic). Data are assessed at one time point only. Survey participants may be assessed at any point between diagnosis and 4 years post-diagnosis. The questions in the survey typically ask about health-related quality of life in the preceding 4 weeks.

Outcome Time Frame:

Duration of Study

Safety Issue:

No

Principal Investigator

David M Latini, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Baylor College of Medicine

Authority:

United States: Institutional Review Board

Study ID:

SDU07-BlCa-PRO

NCT ID:

NCT01090388

Start Date:

July 2007

Completion Date:

December 2012

Related Keywords:

• Bladder Neoplasms
• Cross-sectional survey
• Health-related quality of life
• Symptom management
• Urinary Bladder Neoplasms
• Neoplasms